Search

Your search keyword '"Gal Yadid"' showing total 12 results
Start Over "Gal Yadid" Language english Publisher right vision media
12 results on '"Gal Yadid"'

2. Pluri Teams Up with Bar-Ilan University to Create PLX Cells for Cocaine Addiction Therapy

Subjects
Cocaine, Drug abuse -- Care and treatment, Substance abuse -- Care and treatment, General interest, News, opinion and commentary, Bar-Ilan University
Abstract

HAIFA: Pluri Inc., a biotech company, has signed an agreement with BIRAD-Research & Development Company Ltd., the commercial arm of Bar-Ilan University, to develop Pluri's PLX cells for the treatment [...]

Published
2023

3. Clearmind Medicine Achieved Positive Results in Cocaine Addiction Treatment

Subjects
Cocaine, Drug abuse, Substance abuse -- Care and treatment, General interest, News, opinion and commentary
Abstract

Tel Aviv, Israel / Vancouver, Canada: Clearmind Medicine Inc has issued the following news release: Clearmind Medicine Inc. (Nasdaq, CSE: CMND), (FSE: CWY) ('Clearmind' or the 'company'), a biotech company [...]

Published
2023

4. Israeli Biotech Clearmind Medicine Announced Positive Pre-Clinical Results Treating Major Depression With a Novel Ketamine-Based Compound

Subjects
Major depressive disorder, Ketamine, Biotechnology, Biotechnology industry, General interest, News, opinion and commentary
Abstract

Tel Aviv: Clearmind Medicine Inc. (NASDAQ: CMND) (CSE: CMND), (FSE: CWY) (Clearmind or the Company), a biotech company focused on discovery and development of novel psychedelic-derived therapeutics to solve major [...]

Published
2023

5. SciSparc Announces Additional Positive Result from the Third Part of Clearmind Medicine Inc. Pre-Clinical Study for Cocaine Addiction Treatment

Subjects
Clinical trials -- Research, Cocaine -- Research, Drug abuse -- Care and treatment -- Research, Substance abuse -- Care and treatment, General interest, News, opinion and commentary
Abstract

TEL AVIV: SciSparc Ltd. (Nasdaq: SPRC) ('Company' or 'SciSparc'), a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders of the central nervous system, today announced [...]

Published
2023

6. Israel-Based Clearmind Issues Additional Positive Results from the Third Part of its Pre-Clinical Study for Cocaine Addiction Treatment

Subjects
Clinical trials -- Research, Cocaine -- Research, Drug abuse -- Research, Substance abuse -- Care and treatment, General interest, News, opinion and commentary
Abstract

Tel Aviv: Clearmind Medicine Inc., a biotech company focused on discovery and development of novel psychedelic-derived therapeutics to solve major under-treated health problems, announced additional positive pre-clinical results in its [...]

Published
2023

7. SciSparc Ltd. Announced Additional Positive Results for the Cocaine Addiction Treatment of its Psychedelic-based Pharma Collaboration with Clearmind Medicine Inc

Subjects
Cocaine, Drug abuse, Substance abuse -- Care and treatment, Company earnings/profit, Business, international
Abstract

TEL AVIV: SciSparc Ltd. (Nasdaq: SPRC), a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders of the central nervous system (the Company or SciSparc), today [...]

Published
2022

9. Clearmind Medicine Issues Positive Pre-Clinical Results for Cocaine Addiction Treatment

Subjects
Cocaine, Substance abuse -- Care and treatment, Business, international
Abstract

VANCOUVER: Clearmind Medicine Inc., a biotech company focused on the discovery and development of novel psychedelic-derived therapeutics to solve major undertreated health problems, announced positive pre-clinical results for its treatment [...]

Published
2022

10. SciSparc Ltd. Reports Initial Positive Results for the Cocaine Addiction Treatment of Clearmind Medicine Inc

Subjects
Cocaine, Drug abuse -- Drug therapy, Substance abuse -- Care and treatment, Company earnings/profit, Business, international
Abstract

TEL AVIV, Israel: SciSparc Ltd., a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders of the central nervous system announced that initial positive pre-clinical results [...]

Published
2022

11. Rising Cases Of Mental Health Disorders of Stress, Anxiety & Addiction Fueling Need for Central Nervous System Therapeutics

Subjects
Biogen Inc., Biological products industry, Multiple sclerosis, Mental health, Evidence-based medicine, Central nervous system, Stress (Psychology), General interest, News, opinion and commentary
Abstract

PALM BEACH: FinancialNewsMedia.com has issued the following news release: FinancialNewsMedia.com News Commentary - The global Central Nervous System (CNS) treatments and its market revenues had been steadily growing pre-pandemic and [...]

Published
2022

Catalog

Books, media, physical & digital resources
See catalog results